[Hepatocyte growth factor attenuates ischemia/reperfusion induced cardiomyocyte apoptosis via downregulating calcium

Ling Yan1, Tie-Bing Zhu, Lian-Sheng Wang

  • 1Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Insights

Hepatocyte growth factor (HGF) protects cardiomyocytes from ischemia/reperfusion (I/R) injury by downregulating calcium-sensing receptor (CaSR) mRNA expression. This mechanism involves promoting Bcl-2, suppressing Caspase-3, and activating the PI3K signaling pathway.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cellular Stress Response

Context:

  • Ischemia/reperfusion (I/R) injury is a major cause of cardiomyocyte death.
  • The calcium-sensing receptor (CaSR) plays a role in cellular responses to I/R.
  • Hepatocyte growth factor (HGF) is known to have protective effects in cardiovascular conditions.

Purpose:

  • To investigate the association between the anti-apoptotic effect of HGF in cardiomyocytes undergoing I/R and the expression of CaSR mRNA.
  • To elucidate the molecular mechanisms by which HGF confers protection against I/R-induced cardiomyocyte apoptosis.

Summary:

  • I/R injury significantly increased cardiomyocyte apoptosis and CaSR mRNA expression.
  • HGF treatment reduced I/R-induced apoptosis, suppressed Caspase-3, upregulated Bcl-2, and promoted PI3K phosphorylation.
  • These protective effects of HGF were accompanied by a significant downregulation of CaSR mRNA expression.

Impact:

  • This study reveals a novel mechanism for HGF-mediated cardioprotection.
  • Targeting CaSR expression could be a potential therapeutic strategy for I/R injury.
  • Understanding the interplay between HGF, CaSR, and apoptosis pathways offers insights into managing ischemic heart disease.
Abstract

Related Concept Videos